Advancing Sustainable Development Through Machine-Learning-Based Cancer Prediction

Cancer is a catastrophic disease that affects a significant global health. With the help of early detection and accurate prediction of cancer, patient’s condition can be improved as well as mortality rates can also be reduced. This term paper explores the application of machine-learning techniques in cancer prediction, focusing on their role in assisting health-care professionals in diagnosing cancer at an earlier stage. Paper begins by providing an overview of cancer, its prevalence, and the critical need for early detection. It emphasizes on the potential of machine-learning algorithms to analyze complex datasets for identifying cancerous patterns. The main body of the paper delves into the various machine-learning approaches employed in cancer prediction. Additionally, the paper discusses the significance of feature selection, data pre-processing, and model evaluation techniques in building accurate cancer prediction models. The term paper addresses challenges and considerations associated with implementing machine learning in a clinical setting. These challenges include data privacy, model interpretability, and the need for large, high-quality datasets. Several case studies and research findings are presented to illustrate the effectiveness of ML in cancer prediction. These studies highlight the successful application of machine-learning models in various cancer types such as breast, lung, and prostate cancer, and showcase their potential to augment health-care professionals’ decision-making processes. In sum, this term paper underscores the promising role of ML models in revolutionizing cancer prediction and early diagnosis. Highlighting the significance of interdisciplinary teamwork among data scientists, health-care professionals, and researchers is crucial for unlocking the complete capabilities of machine learning in combating cancer. With ongoing technological progress, incorporating ML algorithms into clinical applications holds the potential to enhance patient outcomes and alleviate the global burden of cancer.